当前位置:首页 - 行情中心 - 翔宇医疗(688626) - 财务分析 - 现金流量表

翔宇医疗

(688626)

  

流通市值:66.24亿  总市值:66.24亿
流通股本:1.60亿   总股本:1.60亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金599,428,965.83445,958,526.46195,165,280.42941,559,024.65
  收到的税费返还16,572,401.2412,821,456.833,500,993.1517,674,654.48
  收到其他与经营活动有关的现金30,121,887.0617,140,401.178,506,060.5466,629,874.91
  经营活动现金流入小计646,123,254.13475,920,384.46207,172,334.111,025,863,554.04
  购买商品、接受劳务支付的现金218,510,449.01177,567,478.3961,411,784.56272,586,969.7
  支付给职工以及为职工支付的现金221,526,936.65152,852,421.1769,991,849.39305,448,020.96
  支付的各项税费46,659,934.8629,861,709.2316,022,223.8764,824,266.6
  支付其他与经营活动有关的现金103,818,041.9671,698,088.4935,883,750.59193,187,517.22
  经营活动现金流出小计590,515,362.48431,979,697.28183,309,608.41836,046,774.48
  经营活动产生的现金流量净额55,607,891.6543,940,687.1823,862,725.7189,816,779.56
二、投资活动产生的现金流量:
  收回投资收到的现金7,000,0007,000,000--
  取得投资收益收到的现金1,492,481.48-299,285.06923,882.89
  处置固定资产、无形资产和其他长期资产收回的现金净额129,43010,000-79,638.27
  处置子公司及其他营业单位收到的现金净额---5,150,712
  收到的其他与投资活动有关的现金755,786,610.46475,786,610.465,000,000180,000,000
  投资活动现金流入小计764,408,521.94482,796,610.465,299,285.06186,154,233.16
  购建固定资产、无形资产和其他长期资产支付的现金147,130,894.17116,681,314.4437,060,678.27287,183,038.88
  投资支付的现金24,870,00020,000,00010,000,0005,750,000
  支付其他与投资活动有关的现金455,000,000299,278,960.4825,000,000289,509,726.01
  投资活动现金流出小计627,000,894.17435,960,274.9272,060,678.27582,442,764.89
  投资活动产生的现金流量净额137,407,627.7746,836,335.54-66,761,393.21-396,288,531.73
三、筹资活动产生的现金流量:
  取得借款收到的现金194,852,156.62164,852,156.62164,852,156.62300,626,243.38
  收到其他与筹资活动有关的现金365,400,000365,400,000294,900,000507,587,160
  筹资活动现金流入小计560,252,156.62530,252,156.62459,752,156.62808,213,403.38
  偿还债务支付的现金130,668,714.17130,668,714.1710,000,000529,707,400
  分配股利、利润或偿付利息支付的现金30,983,594.8630,796,710.52,208,760.7344,434,165.5
  支付其他与筹资活动有关的现金663,074,016.16398,086,625.72348,500,00047,007,519.35
  筹资活动现金流出小计824,726,325.19559,552,050.39360,708,760.73621,149,084.85
  筹资活动产生的现金流量净额-264,474,168.57-29,299,893.7799,043,395.89187,064,318.53
四、汇率变动对现金及现金等价物的影响-493,275.58273,518.51178,012.27-249,523.56
五、现金及现金等价物净增加额-71,951,924.7361,750,647.4656,322,740.65-19,656,957.2
  加:期初现金及现金等价物余额683,255,595.23683,255,595.23683,255,595.23702,912,552.43
  期末现金及现金等价物余额611,303,670.5745,006,242.69739,578,335.88683,255,595.23
补充资料:
  净利润-39,894,339.69-75,986,946.04
  资产减值准备-4,325,780.07-8,064,545.2
  固定资产和投资性房地产折旧-22,584,452.8-43,966,500.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-22,584,452.8-43,966,500.38
  无形资产摊销-5,883,108.68-8,627,545.1
  长期待摊费用摊销-2,981,048.3-8,170,632.91
  处置固定资产、无形资产和其他长期资产的损失--8,964.16--26,252.93
  固定资产报废损失---178,374.86
  公允价值变动损失--590,542.25--501,026
  财务费用-2,977,629.01-5,886,655.58
  投资损失--6,279,726.16--5,939,079.55
  递延所得税--4,576,429.33--4,366,403.22
  其中:递延所得税资产减少--4,576,429.33--4,366,403.22
  存货的减少--54,724,897.62--74,267,559.48
  经营性应收项目的减少--3,161,172.24-5,130,536.48
  经营性应付项目的增加-28,656,797.45-95,810,648.89
  其他---16,581,049.95
  现金的期末余额-745,006,242.69-683,255,595.23
  减:现金的期初余额-683,255,595.23-702,912,552.43
  现金及现金等价物的净增加额-61,750,647.46--19,656,957.2
公告日期2026-10-302026-08-292026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑